- Home
- GROV vs AXDX Comparison
GROV vs AXDX Comparison
Compare GROV & AXDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GROV
- AXDX
- Stock Information
- Founded
- GROV 2016
- AXDX 1982
- Country
- GROV United States
- AXDX United States
- Employees
- GROV N/A
- AXDX N/A
- Industry
- GROV Package Goods/Cosmetics
- AXDX Biotechnology: Laboratory Analytical Instruments
- Sector
- GROV Consumer Discretionary
- AXDX Industrials
- Exchange
- GROV Nasdaq
- AXDX Nasdaq
- Market Cap
- GROV 50.6M
- AXDX 43.8M
- IPO Year
- GROV N/A
- AXDX 1996
- Fundamental
- Price
- GROV $1.39
- AXDX $1.86
- Analyst Decision
- GROV Buy
- AXDX Hold
- Analyst Count
- GROV 1
- AXDX 1
- Target Price
- GROV $2.00
- AXDX $1.00
- AVG Volume (30 Days)
- GROV 152.5K
- AXDX 64.1K
- Earning Date
- GROV 11-07-2024
- AXDX 11-07-2024
- Dividend Yield
- GROV N/A
- AXDX N/A
- EPS Growth
- GROV N/A
- AXDX N/A
- EPS
- GROV N/A
- AXDX N/A
- Revenue
- GROV $227,251,000.00
- AXDX $12,233,000.00
- Revenue This Year
- GROV N/A
- AXDX $1.50
- Revenue Next Year
- GROV $5.97
- AXDX $4.17
- P/E Ratio
- GROV N/A
- AXDX N/A
- Revenue Growth
- GROV N/A
- AXDX 4.87
- 52 Week Low
- GROV $1.19
- AXDX $0.73
- 52 Week High
- GROV $2.49
- AXDX $6.39
- Technical
- Relative Strength Index (RSI)
- GROV 55.14
- AXDX 55.68
- Support Level
- GROV $1.28
- AXDX $1.72
- Resistance Level
- GROV $1.59
- AXDX $1.91
- Average True Range (ATR)
- GROV 0.09
- AXDX 0.13
- MACD
- GROV 0.02
- AXDX -0.00
- Stochastic Oscillator
- GROV 39.42
- AXDX 62.50
About GROV Grove Collaborative Holdings Inc.
Grove Collaborative Holdings Inc is engaged in providing consumer products. It offers Cleaning accessories, Home and Pantry, Personal care products, Pets supplements and Other products.
About AXDX Accelerate Diagnostics Inc.
Accelerate Diagnostics Inc is an in vitro diagnostics company that specializes in rapid diagnostics for infectious pathogens. The firm's core platform, the Accelerate ID/AST System, determines whether live bacterial or fungal cells in a patient sample are susceptible to a particular antibiotic. This test is performed on pathogens that are commonly associated with serious infections and can deliver results more quickly than traditional methods, such as bacterial culturing. The system can analyze a positive blood culture sample in approximately five hours, which is faster than traditional testing techniques. The company earns majority of its revenue from domestic market.